Elderly health insurance premium subsidy proposed Chen Liyin: I am willing to pay it myself if I have the ability

The amendment to the elderly health insurance premium subsidy law has triggered discussions. Chen Liyin, founder of the Rare Disease Foundation, said that disadvantaged elderly people do need support, but she has an annuity and retirement pension and is willing to pay health insurance premiums within her ability. "I want to be an independent elderly person" and do not want to rely on her children's insurance. She also reminded that when discussing premium subsidies for the elderly and insurance for dependent children, the income and affordability of young people should also be considered.

Chen Liyin did not express support or opposition to the elderly health insurance premium subsidy. She said that many elderly and vulnerable elderly people do need support, but as far as she is concerned, because there are some annuities and pensions, "I can do what I can, and I am willing to pay for it myself."

Please read on...

Chen Liyin recalled that as early as 2024, she wrote on Facebook, "I want to be an independent elderly person."

She said that if the elderly depend on their children to apply for insurance, the financial status of the children should also be considered, and the burden on the young cannot be ignored. "Can his income be dependent on so many people?" If the elderly's premiums are subsidized by the government, the issue of dependent insurance will be different. Therefore, this issue should be discussed at several levels.

When it comes to health insurance financial resources, Chen Liyin believes that after the bill is passed, it will be necessary to clarify how the relevant financial resources will be arranged, whether it will involve a government burden, and whether it should cooperate with the amendment of the health insurance law.

As for the outside world's concern about whether rare disease care resources will be affected? Chen Liyin said, "We don't know whether it will be affected." The relevant resource allocation still involves negotiation on the total amount of health insurance, and it is still unclear how the rare disease part will be affected.